Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Blood (2016) 128 (22): 500.

https://doi.org/10.1182/blood.V128.22.500.500

Published: 2016

Journal Articles

Generation of Natural Killer Cell Lymphoma Models In Vitro by Gene Editing

Gehong Dong, PhD, Yuping Li, PhD, Bei Jiang, Jiing-Kuan Yee, Dean A. Lee, MD PhD, Timothy W. McKeithan, MD PhD, Wing Chung Chan, MD

Blood (2016) 128 (22): 2724.

https://doi.org/10.1182/blood.V128.22.2724.2724

Published: 2016

Journal Articles

Pre-Emptive Donor Lymphocyte Infusion with CD19-Directed, CAR-Modified T Cells Infused after Allogeneic Hematopoietic Cell Transplantation for Patients with Advanced CD19 + Malignancies

Blood (2015) 126 (23): 862.

https://doi.org/10.1182/blood.V126.23.862.862

Published: 2015

Journal Articles

Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study

Blood (2015) 126 (23): 929.

https://doi.org/10.1182/blood.V126.23.929.929

Published: 2015

Journal Articles

Results of a Two-Arm Phase II Clinical Trial Using Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease in Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem-Cell Transplantation

Blood (2015) 126 (23): 152.

https://doi.org/10.1182/blood.V126.23.152.152

Published: 2015

Journal Articles

Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Dana B. Willis, Sairah Ahmed, MD, Eric Yvon, PhD, Katayoun Rezvani, MDPhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD

Blood (2015) 126 (23): 102.

https://doi.org/10.1182/blood.V126.23.102.102

Published: 2015

Journal Articles

Cathepsin G Is Broadly Expressed By AML and Is an Effective Immunotherapeutic Target Against AML in Vivo

Gheath Alatrash, DO, PhD, Mao Zhang, MPH, Pariya Sukhumalchandra, BS, Yihua Qiu, MD, Amjad H. Talukder, PhD, Vladimir Senyukov, PhD, Lisa S. St. John, PhD, Hong He, MD, Anna Sergeeva, PhD, Jason Roszik, PhD, Karen Clise-Dwyer, PhD, Sijie Lu, PhD, Qing Ma, PhD, Elizabeth A. Mittendorf, MD PhD, Dean A. Lee, MD PhD, David H Hawke, PhD, Lizee Gregory, PhD, Jeffrey J. Molldrem, Steven M. Kornblau, MD

Blood (2014) 124 (21): 3761.

https://doi.org/10.1182/blood.V124.21.3761.3761

Published: 2014

Journal Articles

Novel Approach for NK Cell Therapy for Cancer

Reshmi Parameswaran, PhD, David N. Wald, MD PhD, Marcos De Lima, MD, Dean A. Lee, MD PhD, Stephen Moreton

Blood (2014) 124 (21): 3836.

https://doi.org/10.1182/blood.V124.21.3836.3836

Published: 2014

Journal Articles

NK Cell Deficiency In Job Syndrome Patients With Dominant Negative STAT3 Mutations

Prasad V Phatarpekar, Emily M Mace, PhD, Jordan S Orange, MD, PhD, Alexandra F Freeman, MD, Steven M. Holland, MD, Dean A. Lee, MD, PhD

Blood (2013) 122 (21): 3476.

https://doi.org/10.1182/blood.V122.21.3476.3476

Published: 2013

Journal Articles

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

Blood (2013) 122 (21): 2167.

https://doi.org/10.1182/blood.V122.21.2167.2167

Published: 2013

Journal Articles

KIR Ligation During Ex Vivo Expansion Allows Molding Of The KIR Repertoire

Dean A. Lee, MD, PhD, Vladimir V Senyukov, PhD, Jerome R Trembley

Blood (2013) 122 (21): 2288.

https://doi.org/10.1182/blood.V122.21.2288.2288

Published: 2013

Journal Articles

Is There An Expiration Date For Cord Blood Units In Storage?

Simrit Parmar, MD, Marcos J de Lima, MD, Dean A. Lee, MD, PhD, Laura Worth, MD, PhD, Piyanuch Kongtim, MD, Demetrios Petropoulos, MD, Ian K. McNiece, PhD, Elizabeth J. Shpall, MD, Gabriela Rondon, MD, Richard E Champlin, MD

Blood (2013) 122 (21): 299.

https://doi.org/10.1182/blood.V122.21.299.299

Published: 2013

Journal Articles

NK Cell Deficiency in Job's Syndrome Patients

Prasad Phatarpekar, Emily Mace, PhD, Jordan Orange, MD, PhD, Alexandra Freeman, MD, Steven M. Holland, MD, Dean A. Lee, MD, PhD

Blood (2012) 120 (21): 3293.

https://doi.org/10.1182/blood.V120.21.3293.3293

Published: 2012

Journal Articles

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

Dongxia Xing, Ph. D., Alan G. Ramsay, PhD, William Decker, PhD, Dean A. Lee, MD, PhD, Simon Robinson, PhD, Nina Shah, MD, Simrit Parmar, M.D., Catherine M. Bollard, MD, FRACP, FRCPA, Chitra M Hosing, MD, Richard Champlin, MD, John G. Gribben, MD, DSc, Elizabeth J Shpall, MD

Blood (2011) 118 (21): 246.

https://doi.org/10.1182/blood.V118.21.246.246

Published: 2011

Journal Articles

Ewing Sarcoma Cells Are Sensitized to NK Cell Mediated Killing by SNDX-275, An HDAC Inhibitor

Anish K. Ray, MBBS, MD, Dean A. Lee, MD, PhD

Blood (2011) 118 (21): 1126.

https://doi.org/10.1182/blood.V118.21.1126.1126

Published: 2011

Journal Articles

NK Cell Proliferation and Cytolytic Function Are Compromised In the Hypoxic Tumor Microenvironment

Sonny Ang, PhD, Maria Lima Da Silva, PhD, Margaret Dawson, PhD, Matthew Figliola, PhD, Sourindra Maiti, PhD, Helen Huls, PhD, Elizabeth J. Shpall, PhD, Richard Champlin, Dean A. Lee, MD, PhD, Lucia Silla, MD, PhD, Laurence J.N. Cooper, MD, PhD

Blood (2010) 116 (21): 4291.

https://doi.org/10.1182/blood.V116.21.4291.4291

Published: 2010

Journal Articles

Combination of Gene Therapy and Nanoparticle Imaging for Improving T-Cell Therapy.

Yoonsu Choi, PhD, Zheng Li, PhD, Xukui Wang, MD, Hui Li, PhD, Feng Li, PhD, Daniel Y Lee, MD, PhD, Parijat Bhatnagar, PhD, Ching H Tung, PhD, Sibani L Biswal, PhD, Dean A. Lee, MD, PhD, King C Li, MD, MBA, Laurence J.N. Cooper, MD, PhD

Blood (2010) 116 (21): 1479.

https://doi.org/10.1182/blood.V116.21.1479.1479

Published: 2010

Journal Articles

NK-Cell Acquisition of Chemokine Receptors From Engineered Antigen Presenting Cells

Srinivas S. Somanchi, PhD, Anitha Gururajan, Laurence J.N. Cooper, MD, PhD, Dean A. Lee, MD, PhD

Blood (2010) 116 (21): 1744.

https://doi.org/10.1182/blood.V116.21.1744.1744

Published: 2010

Journal Articles

Alloreactive Nk Cells to Augment Antileukemia Cytotoxicity with Allogeneic Stem Cell Transplantation for Aml/Mds: A Phase I Study

Richard Champlin, Dean A. Lee, MD, PhD, Marcelo Fernandez-Vina, PhD, Gabriela Rondon, MD, Patricia McAdams, RN, Chen Julianne, Muzaffar H. Qazilbash, MD, Partow Kebriaei, MD, Simrit Parmar, MBBS, Elizabeth J. Shpall, Uday Popat, MD, Amin Alousi, MD, Stefan O. Ciurea, MD, Laurence Cooper, MD, PhD, Thall Peter, John McMannis, PhD

Blood (2010) 116 (21): 489.

https://doi.org/10.1182/blood.V116.21.489.489

Published: 2010

Journal Articles

STAT3 Activation Promotes NK Cell Proliferation, NKG2D Expression, and NK Cell Antitumor Activity

Prasad Phatarpekar, Shiguo Zhu, MD, PhD, Cecele J. Denman, Nam Nguyen-Jackson, Stephanie S. Watowich, PhD, Laurence J.N. Cooper, MD, PhD, Dean A. Lee, MD, PhD

Blood (2010) 116 (21): 105.

https://doi.org/10.1182/blood.V116.21.105.105

Published: 2010

NARROW

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Generation of Natural Killer Cell Lymphoma Models In Vitro by Gene Editing

Pre-Emptive Donor Lymphocyte Infusion with CD19-Directed, CAR-Modified T Cells Infused after Allogeneic Hematopoietic Cell Transplantation for Patients with Advanced CD19 + Malignancies

Infusion of Ex Vivo Expanded Allogeneic Cord Blood-Derived Natural Killer Cells in Combination with Autologous Stem Cell Transplantation for Multiple Myeloma: Results of a Phase I Study

Results of a Two-Arm Phase II Clinical Trial Using Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease in Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem-Cell Transplantation

Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias

Cathepsin G Is Broadly Expressed By AML and Is an Effective Immunotherapeutic Target Against AML in Vivo

Novel Approach for NK Cell Therapy for Cancer

NK Cell Deficiency In Job Syndrome Patients With Dominant Negative STAT3 Mutations

Transplant Outcomes For Patients With AML/MDS Using Melphalan-Based Conditioning

KIR Ligation During Ex Vivo Expansion Allows Molding Of The KIR Repertoire

Is There An Expiration Date For Cord Blood Units In Storage?

NK Cell Deficiency in Job's Syndrome Patients

CD137L Reverse the Immunological Synapse Defects of Natural Killer Cells in Acute Myeloid Leukemia

Ewing Sarcoma Cells Are Sensitized to NK Cell Mediated Killing by SNDX-275, An HDAC Inhibitor

NK Cell Proliferation and Cytolytic Function Are Compromised In the Hypoxic Tumor Microenvironment

Combination of Gene Therapy and Nanoparticle Imaging for Improving T-Cell Therapy.

NK-Cell Acquisition of Chemokine Receptors From Engineered Antigen Presenting Cells

Alloreactive Nk Cells to Augment Antileukemia Cytotoxicity with Allogeneic Stem Cell Transplantation for Aml/Mds: A Phase I Study

STAT3 Activation Promotes NK Cell Proliferation, NKG2D Expression, and NK Cell Antitumor Activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only